Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Blue Owl Capital Holdings

Latest statistics and disclosures from Blue Owl Capital Holdings's latest quarterly 13F-HR filing:

Top 5 stock holdings are AKTS, LRMR, Engene Holdings, NCDL, CGEM, and represent 47.12% of Blue Owl Capital Holdings's stock portfolio.
Added to shares of these 10 stocks: AKTS (+$57M), MPLT (+$14M), CRVS (+$8.0M), Engene Holdings (+$7.2M), EYPT (+$6.7M), RYTM (+$5.3M), OVID, AQST, LENZ, STWD.
Started 20 new stock positions in CAI, Viking Therapeutics Inc call, STWD, Vodafone Group, EVMN, Structure Therapeutics, Larimar Therapeutics, Compass Therapeutics, PIPR, CRVS. KPLT, Olema Pharmaceuticals, WW, Compass Pathways, AKTS, RYTM, Mineralys Therapeutics, OVID, ET, Gohealth Inc Cl A.
Reduced shares in these 10 stocks: Repare Therapeutics Ord (-$9.0M), PCOR (-$6.9M), DELL (-$6.6M), CGEM (-$6.3M), CNTX (-$6.1M), ROIV (-$5.7M), CVEO (-$5.0M), SGMT, ORIC, IMRX.
Sold out of its positions in ANGX, BSLKW, Centessa Pharmaceuticals, CHYM, CMPS, CXAIW, BLNE, IMRX, JANX, LVWR.WS.
Blue Owl Capital Holdings was a net buyer of stock by $32M.
Blue Owl Capital Holdings has $367M in assets under management (AUM), dropping by 13.35%.
Central Index Key (CIK): 0001858703

Tip: Access up to 7 years of quarterly data

Positions held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Blue Owl Capital Holdings

Blue Owl Capital Holdings holds 75 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Aktis Oncology (AKTS)	15.4	$57M	NEW	3.2M	17.89	View chart
Larimar Therapeutics (LRMR)	8.7	$32M	+4%	7.1M	4.50	View chart
Engene Holdings	8.2	$30M	+31%	4.4M	6.81	View chart
Nuveen Churchill Direct Lend Com Shs (NCDL)	7.4	$27M		2.1M	12.72	View chart
Cullinan Oncology (CGEM)	7.4	$27M	-18%	1.9M	14.21	View chart
Owl Rock Capital Corporation (OBDC)	6.2	$23M		2.0M	11.06	View chart
Maplight Therapeutics (MPLT)	5.6	$21M	+207%	1.0M	20.33	View chart
Compass Therapeutics (CMPX)	4.2	$16M	-15%	2.9M	5.29	View chart
Context Therapeutics (CNTX)	3.6	$13M	-31%	5.1M	2.62	View chart
Holley (HLLY)	3.5	$13M	+2%	4.2M	3.07	View chart
Eyepoint Com New (EYPT)	3.2	$12M	+132%	913k	12.89	View chart
Corvus Pharmaceuticals (CRVS)	2.2	$8.0M	NEW	545k	14.63	View chart
Conduent Incorporate (CNDT)	1.8	$6.4M	+4%	5.0M	1.28	View chart
Ultragenyx Pharmaceutical (RARE)	1.7	$6.3M	+42%	303k	20.95	View chart
Aquestive Therapeutics (AQST)	1.5	$5.6M	+156%	1.3M	4.15	View chart
Rhythm Pharmaceuticals (RYTM)	1.5	$5.3M	NEW	62k	86.97	View chart
Immix Biopharma (IMMX)	1.4	$5.0M	-44%	548k	9.11	View chart
Imagenebio (IMA)	1.3	$4.8M	+16%	959k	5.00	View chart
Civeo Corp Cda Com New (CVEO)	1.3	$4.8M	-51%	181k	26.46	View chart
Lenz Therapeutics (LENZ)	1.3	$4.6M	+237%	507k	9.15	View chart
Eledon Pharmaceuticals (ELDN)	1.2	$4.4M	-26%	1.4M	3.08	View chart
Kalvista Pharmaceuticals	1.2	$4.3M	-40%	215k	20.13	View chart
Ovid Therapeutics (OVID)	1.2	$4.2M	NEW	1.9M	2.22	View chart
Palvella Therapeutics Inc Ne (PVLA)	1.1	$3.9M	-22%	31k	124.65	View chart
Pliant Therapeutics (PLRX)	1.0	$3.7M		3.0M	1.26	View chart
Starwood Property Trust (STWD)	0.7	$2.7M	NEW	159k	17.22	View chart
Adc Therapeutics Sa SHS (ADCT)	0.7	$2.6M		734k	3.53	View chart
Evommune Com Shs (EVMN)	0.6	$2.3M	NEW	100k	22.99	View chart
Dell Technologies CL C (DELL)	0.6	$2.3M	-74%	14k	164.13	View chart
Larimar Therapeutics Call	0.5	$1.9M	NEW	976k	1.96	View chart
Oric Pharmaceuticals (ORIC)	0.5	$1.9M	-70%	150k	12.67	View chart
Sagimet Biosciences Com Ser A (SGMT)	0.5	$1.7M	-73%	334k	5.22	View chart
Ww Intl Com New (WW)	0.4	$1.3M	NEW	96k	13.74	View chart
Engene Holdings *w Exp 10/31/202 (ENGNW)	0.4	$1.3M	+1316%	511k	2.53	View chart
Enterprise Products Partners (EPD)	0.3	$1.2M		31k	37.84	View chart
Fold Hldgs Com Cl A (FLD)	0.3	$1.1M		857k	1.32	View chart
Syntec Optics Hldgs *w Exp 99/99/999 (OPTXW)	0.2	$867k		803k	1.08	View chart
Marker Therapeutics Com New (MRKR)	0.2	$721k		554k	1.30	View chart
Mineralys Therapeutics Call	0.2	$590k	NEW	200k	2.95	View chart
Niocorp Devs *w Exp 03/17/202 (NIOBW)	0.1	$525k	-63%	320k	1.64	View chart
Compass Therapeutics Call	0.1	$500k	NEW	400k	1.25	View chart
Brand Engagement Network *w Exp 03/14/202 (BNAIW)	0.1	$417k	-38%	1.7M	0.25	View chart
Cardinal Health (CAH)	0.1	$363k		1.7k	211.31	View chart
Compass Pathways Call	0.1	$265k	NEW	1.8M	0.15	View chart
Rezolve Ai *w Exp 08/15/202 (RZLVW)	0.1	$202k	-18%	235k	0.86	View chart
Piper Sandler Companies Com New (PIPR)	0.1	$186k	NEW	2.4k	76.55	View chart
Alpha Modus Hldgs Cl A (AMOD)	0.0	$146k		394k	0.37	View chart
Energy Transfer Com Ut Ltd Ptn (ET)	0.0	$103k	NEW	5.3k	19.30	View chart
CID Holdco (DAIC)	0.0	$95k		557k	0.17	View chart
Caris Life Sciences (CAI)	0.0	$84k	NEW	4.7k	17.88	View chart
Vodafone Group Sponsored Adr	0.0	$81k	NEW	5.4k	15.02	View chart
Alpha Modus Hldgs *w Exp 12/13/20 (AMODW)	0.0	$74k		1.9M	0.04	View chart
Viking Therapeutics Call	0.0	$68k	NEW	50k	1.36	View chart
Shf Holdings Cl A New (SHFS)	0.0	$63k		76k	0.83	View chart
Gohealth Cl A New	0.0	$62k	NEW	41k	1.51	View chart
Aeon Biopharma Cl A New (AEON)	0.0	$42k	-2%	42k	0.98	View chart
Blue Gold *w Exp 04/01/203 (BGLWW)	0.0	$35k		175k	0.20	View chart
Southland Hldgs *w Exp 02/14/202 (SLND.WS)	0.0	$34k		860k	0.04	View chart
Roadzen *w Exp 11/30/202 (RDZNW)	0.0	$32k		225k	0.14	View chart
Structure Therapeutics Call	0.0	$25k	NEW	100k	0.25	View chart
Blacksky Technology *w Exp 09/09/20 (BKSY.WS)	0.0	$14k		350k	0.04	View chart
Olema Pharmaceuticals Call	0.0	$10k	NEW	200k	0.05	View chart
Baird Med Invt Hldgs *w Exp 10/01/202 (BDMDW)	0.0	$9.0k		100k	0.09	View chart
Cid Holdco *w Exp 12/31/202 (DAICW)	0.0	$8.9k	+48%	445k	0.02	View chart
Dave *w Exp 01/05/202 (DAVEW)	0.0	$7.8k		29k	0.27	View chart
Tevogen Bio Hldgs *w Exp 02/14/202 (TVGNW)	0.0	$6.0k		200k	0.03	View chart
Katapult Holdings Com New (KPLT)	0.0	$5.7k	NEW	5.4k	1.06	View chart
Stardust Pwr *w Exp 06/21/202 (SDSTW)	0.0	$2.7k	-47%	17k	0.16	View chart
Liminatus Pharma *w Exp 04/30/203 (LIMNW)	0.0	$2.0k		50k	0.04	View chart
Pagaya Technologies *w Exp 99/99/999 (PGYWW)	0.0	$1.9k		49k	0.04	View chart
Xbp Global Holdings *w Exp 11/30/202 (XBPEW)	0.0	$1.5k		25k	0.06	View chart
Waldencast *w Exp 07/27/202 (WALDW)	0.0	$1.3k		33k	0.04	View chart
Bitcoin Depot *w Exp 06/30/202	0.0	$1.0k		50k	0.02	View chart
Aspire Biopharma Hldgs *w Exp 02/14/203 (ASBPW)	0.0	$1.0k		50k	0.02	View chart
Katapult Holdings *w Exp 06/09/202	0.0	$0		400k	0.00	View chart

Past Filings by Blue Owl Capital Holdings

SEC 13F filings are viewable for Blue Owl Capital Holdings going back to 2021

Blue Owl Capital Holdings 2026 Q1 filed May 14, 2026
Blue Owl Capital Holdings 2025 Q4 restated filed Feb. 20, 2026
Blue Owl Capital Holdings 2025 Q3 filed Nov. 12, 2025
Blue Owl Capital Holdings 2025 Q2 filed Aug. 11, 2025
Blue Owl Capital Holdings 2025 Q1 filed May 15, 2025
Blue Owl Capital Holdings 2024 Q4 filed Feb. 14, 2025
Blue Owl Capital Holdings 2024 Q3 filed Nov. 14, 2024
Blue Owl Capital Holdings 2024 Q2 filed Aug. 15, 2024
Blue Owl Capital Holdings 2024 Q1 filed May 15, 2024
Blue Owl Capital Holdings 2023 Q4 filed Feb. 15, 2024
Blue Owl Capital Holdings 2023 Q3 filed Nov. 14, 2023
Blue Owl Capital Holdings 2023 Q2 filed Aug. 11, 2023
Blue Owl Capital Holdings 2023 Q1 filed May 11, 2023
Blue Owl Capital Holdings 2022 Q4 filed Feb. 13, 2023
Blue Owl Capital Holdings 2022 Q3 filed Nov. 14, 2022
Blue Owl Capital Holdings 2022 Q2 filed Aug. 12, 2022

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z